Literature DB >> 23934478

Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients.

Haruko Ideguchi1, Akiko Suda, Mitsuhiro Takeno, Rumiko Miyagi, Atsuhisa Ueda, Shigeru Ohno, Yoshiaki Ishigatsubo.   

Abstract

We analyzed the clinical gastrointestinal (GI) characteristics of Behçet's disease (BD) patients in Japan. We retrospectively reviewed the clinical charts of 412 patients who fulfilled the 1987 Japanese criteria for BD and were treated in two university hospitals from July 1991 to December 2007. Forty-three patients (10.4 %) had BD-related GI lesions, which were shown by imaging examinations. Median age at BD diagnosis and onset of GI episodes were 29.6 and 31.0 years, respectively. The patients suffered from abdominal pain (30/43) and GI bleeding (18/43), while they had lower frequency of eye involvement and higher incidence of arthritis and vascular involvement than BD patients without GI lesions. The lesions were prevalent in the ileum (32/43) followed by cecum (21/43) and esophagus (9/43). The patients were treated with mesalazine and sulfasalazine (41/43), corticosteroids (32/43), immunosuppressants (13/43), and infliximab for 7 patients having refractory lesions, while 10 patients had surgical operation. Two patients died due to non-GI events during the observation. The diagnosis of BD was often difficult because of lack of eye involvement. Surgery is required for some patients in spite of intensive immunosuppressive therapies. Appropriate use of anti-TNF agents may be promising for the GI involvement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934478     DOI: 10.1007/s00296-013-2838-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Long-term clinical course and prognostic factors in intestinal Behçet's disease.

Authors:  I J Choi; J S Kim; S D Cha; H C Jung; J G Park; I S Song; C Y Kim
Journal:  Dis Colon Rectum       Date:  2000-05       Impact factor: 4.585

2.  EULAR recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-01-31       Impact factor: 19.103

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Gastrointestinal involvement in Behçet's syndrome: a controlled study.

Authors:  S Yurdakul; N Tüzüner; I Yurdakul; V Hamuryudan; H Yazici
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

5.  Anal complication in Behçet's syndrome.

Authors:  T Iwama; J Utzunomiya
Journal:  Jpn J Surg       Date:  1977-09

Review 6.  Recent research into Behçet's disease in Japan.

Authors:  Y Mizushima
Journal:  Int J Tissue React       Date:  1988

Review 7.  Gastrointestinal manifestations of Behcet's disease.

Authors:  Y Bayraktar; E Ozaslan; D H Van Thiel
Journal:  J Clin Gastroenterol       Date:  2000-03       Impact factor: 3.062

8.  Behçet disease: evolution of clinical manifestations.

Authors:  Haruko Ideguchi; Akiko Suda; Mitsuhiro Takeno; Atsuhisa Ueda; Shigeru Ohno; Yoshiaki Ishigatsubo
Journal:  Medicine (Baltimore)       Date:  2011-03       Impact factor: 1.889

Review 9.  Behçet's disease: a new target for anti-tumour necrosis factor treatment.

Authors:  P P Sfikakis
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

10.  The prevalence and clinical characteristics of esophageal involvement in patients with Behçet's disease: a single center experience in Korea.

Authors:  Seung Woo Yi; Jae Hee Cheon; Jie Hyun Kim; Sang Kil Lee; Tae Il Kim; Yong Chan Lee; Won Ho Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

View more
  15 in total

1.  Successful treatment with infliximab for refractory para-ileostomal ulceration in a patient with Behҫet's disease.

Authors:  Mitsuaki Ishioka; Kengo Onochi; Yusato Suzuki; Masayuki Sawaguchi; Natsumi Hatakeyama; Shigeto Koizumi; Tamotsu Matsuhashi; Mario Jin; Hirohide Ohnishi
Journal:  Clin J Gastroenterol       Date:  2015-06-09

2.  Perianal ulcers without genital ulcers: a rare presentation of Behçet's disease.

Authors:  Shimpei Seiki; Yoshinobu Matsuura; Hideaki Terada; Yasuji Doi
Journal:  Rheumatol Adv Pract       Date:  2022-06-09

3.  Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet's disease.

Authors:  Jun Zou; Yan Shen; Da-Nian Ji; Song-Bai Zheng; Jian-Long Guan
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 4.  Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.

Authors:  Yehyun Park; Jae Hee Cheon
Journal:  Curr Gastroenterol Rep       Date:  2020-03-19

5.  Discriminating potential of extraintestinal systemic manifestations and colonoscopic features in Chinese patients with intestinal Behçet's disease and Crohn's disease.

Authors:  Ji Li; Pan Li; Jing Bai; Hong Lyu; Yue Li; Hong Yang; Bo Shen; Jia-Ming Qian
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

6.  Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center.

Authors:  Ibrahim Hatemi; Sinem Nihal Esatoglu; Gulen Hatemi; Yusuf Erzin; Hasan Yazici; Aykut Ferhat Celik
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 7.  Updated treatment strategies for intestinal Behçet's disease.

Authors:  Yong Eun Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2017-12-08       Impact factor: 2.884

Review 8.  Skewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's Disease.

Authors:  Jun Shimizu; Fumio Kaneko; Noboru Suzuki
Journal:  Genet Res Int       Date:  2013-12-30

9.  Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.

Authors:  Mariko Kaji; Takayuki Kishi; Takako Miyamae; Satoru Nagata; Hisashi Yamanaka; Satoshi Fujikawa
Journal:  Case Rep Rheumatol       Date:  2015-11-02

10.  Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study.

Authors:  Yohei Kirino; Haruko Ideguchi; Mitsuhiro Takeno; Akiko Suda; Kana Higashitani; Yosuke Kunishita; Kaoru Takase-Minegishi; Maasa Tamura; Toshiyuki Watanabe; Yukiko Asami; Takeaki Uehara; Ryusuke Yoshimi; Tetsu Yamazaki; Akiko Sekiguchi; Atsushi Ihata; Shigeru Ohno; Atsuhisa Ueda; Toshihisa Igarashi; Shohei Nagaoka; Yoshiaki Ishigatsubo; Hideaki Nakajima
Journal:  Arthritis Res Ther       Date:  2016-10-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.